Exchange: NASDAQ·

ITOSITeos Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsApr 28
Mkt Cap$448.68M
Vol11.01M

About

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
173

Frequently Asked Questions

What is Market Cap of ITeos Therapeutics Inc?
What is the 52-week high for ITeos Therapeutics Inc?
What is the 52-week low for ITeos Therapeutics Inc?
What is ITeos Therapeutics Inc stock price today?
What was ITeos Therapeutics Inc stock price yesterday?
What is the PE ratio of ITeos Therapeutics Inc?
What is the Price-to-Book ratio of ITeos Therapeutics Inc?
What is the 50-day moving average of ITeos Therapeutics Inc?
How many employees does ITeos Therapeutics Inc have?

Advertisement|Remove ads.